Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants

The aim of the research was to study the content of PIVKA-II in the blood serum as an integrative measure of latent vitamin K deficiency in breastfed infants aged from the birth to 6 months of life. Materials and methods. 178 children aged from the birth to 6 months of life who were born without...

Full description

Saved in:
Bibliographic Details
Main Authors: O. G. Ivanko, A. V. Solianik, I. V. Pashchenko
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2017-12-01
Series:Patologìâ
Subjects:
Online Access:http://pat.zsmu.edu.ua/article/view/118319/113896
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399662039007232
author O. G. Ivanko
A. V. Solianik
I. V. Pashchenko
author_facet O. G. Ivanko
A. V. Solianik
I. V. Pashchenko
author_sort O. G. Ivanko
collection DOAJ
description The aim of the research was to study the content of PIVKA-II in the blood serum as an integrative measure of latent vitamin K deficiency in breastfed infants aged from the birth to 6 months of life. Materials and methods. 178 children aged from the birth to 6 months of life who were born without birth injuries in the term of 38–41 of weeks gestation with a weight 2800–4200 g were examined. The immunoenzyme assay for PIVKA-II study was performed with ANTIBODY RESEARCH kit PIVKA-II ELISA Kit (USA) Results. Children who had not received postnatal prophylactic injection of vitamin K1 in dose of 1 mg intramuscularly in their majority (62 %) had abnormally elevated serum PIVKA-II (>40 Au/ml) at the first week of life. In 92 % of children who had received a prophylactic dose of vitamin K1 immediately after birth, PIVKA-II was in a normal limit. The normal concentrations of PIVKA-II were observed in children aged 2–6 months regardless of vitamin K prophylactics. The situation worsened dramatically in children who were treated with antibiotics because more than 50 % of these children have experienced high PIVKA-II values. Conclusions. Almost all the children in their first week of life whom for any reasons vitamin K1 was not prescribed have exhibited an elevation of PIVKA-II in blood serum. This indicates an inborn deficiency of vitamin K experienced by fetuses and newborns. Prophylactic injection of vitamin K1 to newborns normalizes the processes of prothrombin carboxylation and PIVKA-II concentrations are getting normal. Children, who did not receive vitamin K1 after the birth, during the first month of life spontaneously normalize the PIVKA-II concentrations. The improvement of prothrombin carboxylation is obviously connected with the colon microbiota development which can provide children with well absorbed vitamin K2 (menaquinone). In 55.5 % of breastfed children aged up to 6 months who had received antibiotics the PIVKA-II appeared elevated again. This indicates the renewal of the vitamin K deficiency in conditions of the colon microbiota damage.
format Article
id doaj-art-9cf114df281e45ff9da9d4125d9a8d2e
institution Kabale University
issn 2306-8027
2310-1237
language English
publishDate 2017-12-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Patologìâ
spelling doaj-art-9cf114df281e45ff9da9d4125d9a8d2e2025-08-20T03:38:16ZengZaporizhzhia State Medical and Pharmaceutical UniversityPatologìâ2306-80272310-12372017-12-01327628110.14739/2310-1237.2017.3.118319Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infantsO. G. IvankoA. V. SolianikI. V. PashchenkoThe aim of the research was to study the content of PIVKA-II in the blood serum as an integrative measure of latent vitamin K deficiency in breastfed infants aged from the birth to 6 months of life. Materials and methods. 178 children aged from the birth to 6 months of life who were born without birth injuries in the term of 38–41 of weeks gestation with a weight 2800–4200 g were examined. The immunoenzyme assay for PIVKA-II study was performed with ANTIBODY RESEARCH kit PIVKA-II ELISA Kit (USA) Results. Children who had not received postnatal prophylactic injection of vitamin K1 in dose of 1 mg intramuscularly in their majority (62 %) had abnormally elevated serum PIVKA-II (>40 Au/ml) at the first week of life. In 92 % of children who had received a prophylactic dose of vitamin K1 immediately after birth, PIVKA-II was in a normal limit. The normal concentrations of PIVKA-II were observed in children aged 2–6 months regardless of vitamin K prophylactics. The situation worsened dramatically in children who were treated with antibiotics because more than 50 % of these children have experienced high PIVKA-II values. Conclusions. Almost all the children in their first week of life whom for any reasons vitamin K1 was not prescribed have exhibited an elevation of PIVKA-II in blood serum. This indicates an inborn deficiency of vitamin K experienced by fetuses and newborns. Prophylactic injection of vitamin K1 to newborns normalizes the processes of prothrombin carboxylation and PIVKA-II concentrations are getting normal. Children, who did not receive vitamin K1 after the birth, during the first month of life spontaneously normalize the PIVKA-II concentrations. The improvement of prothrombin carboxylation is obviously connected with the colon microbiota development which can provide children with well absorbed vitamin K2 (menaquinone). In 55.5 % of breastfed children aged up to 6 months who had received antibiotics the PIVKA-II appeared elevated again. This indicates the renewal of the vitamin K deficiency in conditions of the colon microbiota damage.http://pat.zsmu.edu.ua/article/view/118319/113896newbornsbreast feedingvitamin KPIVKA-IIantibioticsanti-bacterial agents
spellingShingle O. G. Ivanko
A. V. Solianik
I. V. Pashchenko
Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
Patologìâ
newborns
breast feeding
vitamin K
PIVKA-II
antibiotics
anti-bacterial agents
title Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
title_full Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
title_fullStr Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
title_full_unstemmed Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
title_short Ontogenetic view on PIVKA-II in the development of prothrombin synthesis in infants
title_sort ontogenetic view on pivka ii in the development of prothrombin synthesis in infants
topic newborns
breast feeding
vitamin K
PIVKA-II
antibiotics
anti-bacterial agents
url http://pat.zsmu.edu.ua/article/view/118319/113896
work_keys_str_mv AT ogivanko ontogeneticviewonpivkaiiinthedevelopmentofprothrombinsynthesisininfants
AT avsolianik ontogeneticviewonpivkaiiinthedevelopmentofprothrombinsynthesisininfants
AT ivpashchenko ontogeneticviewonpivkaiiinthedevelopmentofprothrombinsynthesisininfants